According to the latest report “Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023”
The slide stainers market was valued at USD 2.52 billion in 2017 and is expected to reach USD 4.70 billion in 2023, at a CAGR of 11.0% during the forecast period. The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.
Factors contributing to the growth of this market include the increasing incidence of chronic diseases, increasing automation in laboratories, rising geriatric population, and increasing healthcare expenditure.
Download a FREE Pdf Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global slide stainers market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as D&B Hoovers, Bloomberg Business, and Factiva, and annual reports of the companies have been used to identify and collect information useful for the study of this market.
Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
Key Players
The prominent players in the global slide stainers market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US). Read More
The slide stainers market was valued at USD 2.52 billion in 2017 and is expected to reach USD 4.70 billion in 2023, at a CAGR of 11.0% during the forecast period. The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.
Factors contributing to the growth of this market include the increasing incidence of chronic diseases, increasing automation in laboratories, rising geriatric population, and increasing healthcare expenditure.
Download a FREE Pdf Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global slide stainers market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as D&B Hoovers, Bloomberg Business, and Factiva, and annual reports of the companies have been used to identify and collect information useful for the study of this market.
Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
Key Players
The prominent players in the global slide stainers market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US). Read More
Comments
Post a Comment